A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S.
0
0
New research reveals that a treatment called Stem Cell Educator therapy is safe and effective for treating type 1 and type 2 diabetes. The therapy cultures the patient's immune cells with cord blood stem cells and returns ...
11
0
An enzyme implicated in autoimmune diseases and viral infections also regulates radiation therapy's ability to trigger an immune response against cancer, Weill Cornell Medicine scientists found in a new study. Their discovery ...
131
0
Exposure to sunlight releases a compound from the skin that can alleviate symptoms of eczema, research has found.
14
0
For many patients, participating in gene therapy clinical trials isn't an option because their immune system recognizes and fights the helpful virus used for treatment. Now, University of Florida Health and University of ...
86
0
A new study of gene transfer using adeno-associated virus (AAV)-based gene delivery into skeletal muscle of rhesus macaques showed that oral prednisone reduced immune responses to AAV that can weaken expression of the therapeutic ...
0
0
Scientists have armed immune cells with a new surface molecule. This causes the cells to respond particularly aggressively when they encounter a protein that tumors actually use to camouflage themselves from the immune system. ...
61
0
Data demonstrating sustained protein expression five years after a single intramuscular injection of a gene-based therapy for the treatment of alpha-1 antitrypsin (AAT) deficiency also shows improvements in multiple indicators ...
2
0
A single treatment giving life-long protection from severe allergies such as asthma could be made possible by immunology research at The University of Queensland.
1890
0
A novel vaccine therapy can generate immune responses in patients with head and neck squamous cell carcinoma (HNSCCa), according to researchers at the Abramson Cancer Center of the University of Pennsylvania. The treatment ...
1
0
Subscribe to rss feed
